Context. Data regarding prognostication of life expectancy in patients with advanced cancer are of paramount importance to patients, families, and clinicians. However, data regarding patients followed at home are lacking.
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Introduction
Prognostication of life expectancy in patients with advanced cancer is of paramount importance to patients, families, and clinicians. In the last several years, many studies have been done to identify possible predictors of survival in this population. 1e5 However, data regarding patients followed at home are lacking. Most studies of home care have focused on the probabilities of predicting a home death 6e8 rather than on survival. Indeed, communicating survival predictions is an important part of cancer care, even at home, where survival is assumed to be short. 8 Investigating possible factors associated with a shorter survival may help in planning communications and making therapeutic decisions.
The Home Care-Italy group recently has been established, with the intent to disseminate and implement information on cancer patients followed at home, given the paucity of existing data in this setting. As part of its scientific program, this study was undertaken to evaluate the correlation between various factors recorded at the beginning of home care assistance and survival.
Methods
Over a six-month period, we prospectively collected the charts of consecutive patients admitted to two home care programs in L'Aquila and Turin, which belong to the Home CareItaly group. These two programs, which are representative of home care programs in Italy, have been shown to provide a similar level of assistance and have sufficient experience in collecting scientific data. 9 The patients received home visits from physicians (two or three weekly) and nurses (three to seven weekly) and also have access to on-call visits in case of need.
Ethics committee approval and informed consent were obtained from the University of Palermo. A preliminary consensus on the possible variables to be measured was achieved, not only on the basis of the literature 1e5 but primarily based on the feasibility, simplicity, and reproducibility of parameters to be measured at home (excluding biochemical data, for instance). Consensus regarding the final choices was reached after debating these issues at an investigators' meeting.
Patients were then followed at home according to local policies and protocols. The following information was collected (other than survival time): age at the time of home care admission, gender, residence, marital status, primary cancer diagnosis, Karnofsky Performance Status (KPS) score, systolic blood pressure and heart rate, cyanosis, use of oxygen, and body temperature. Symptom severity was recorded using the Edmonton Symptom Assessment System (ESAS). The ESAS is a validated and reliable assessment tool, commonly used in cancer patients to screen for symptom severity. 10 With the ESAS, patients rate the severity of the following symptoms: pain, fatigue, nausea, depression, anxiety, drowsiness, lack of appetite, well-being, and shortness of breath. The sum of the patient's responses is the ESAS distress score. Delirium was evaluated by the clinical judgment of the home care palliative care specialists and by the Mini-Mental State Examination (scores less than 24 of 30 were considered to indicate that delirium was present).
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Patients were divided into two groups: patients with a survival of less than 10 days (short survival) and patients with a survival of 10 days or more (medium-long survival). This was considered by the panel to be an important interval to provide useful information in terms of communication and therapeutic planning.
Statistical Analysis
Statistical analysis of quantitative and qualitative data, including descriptive statistics, was performed for all items. Continuous data are expressed as mean AE SD, unless otherwise specified. One-way analysis of variance was conducted to analyze the possible relationship between clinical variables and survival. Odds ratios and their 95% CIs were calculated using the univariate and multivariate model of logistic regression analysis. Model performance was evaluated using the Hosmer-Lemeshow test for goodness of fit. The continuous variables that were independently prognostic of survival were assessed in univariate and multivariate linear regression models, and slope coefficients with their SEs are presented. Data were analyzed by Epi Info software, version 6.0 (CDC, Atlanta, GA) and SPSS software, version 14.0 (SPSS, Inc., Chicago, IL). All P-values were two-sided, and P-values less than 0.05 were considered to indicate statistical significance.
Results
Three hundred seventy-four consecutive patients admitted to home care programs in L'Aquila and Turin were surveyed. The mean age was 72.1 AE 12.7 years; 187 patients were male. Primary tumor frequency is reported in Table 1 .
Overall mean survival was 56.2 AE 65 days. Mean survival was 71.5 AE 67 days (287 patients) and 5.6 AE 2.7 days (87 patients) in the short and medium-long survival groups, respectively. No association between type of tumor and survival was observed (P ¼ 0.162). On univariate logistic regression analysis, male gender (P ¼ 0.020), older age (P ¼ 0.012), lower KPS score (P < 0.0005), systolic blood pressure less than 100 mm Hg (P ¼ 0.003), heart rate more than 100 beats per minute (P ¼ 0.0006), delirium (P ¼ 0.004), use of oxygen (P ¼ 0.002), intensity of fatigue (P ¼ 0.006), drowsiness (P < 0.0005), appetite loss (P < 0.0005), dyspnea (P < 0.0005), poor sense of well-being (P < 0.0005), and high distress score (P < 0.0005) ( Tables 2 and 3) were associated with a survival of less than 10 days. Marital status, residence, cognitive function, fever, pain, depression, and anxiety were not found to be significantly correlated with survival.
In a multiple logistic regression model, low systolic blood pressure and high heart rate, gender, delirium, use of oxygen, poor KPS score, drowsiness, appetite loss, and dyspnea were significantly correlated with a shorter survival (Tables 2 and 3 ). The Hosmer-Lemeshow goodness-of-fit test for the final model yielded a P-value of 0.640, suggesting the model fits the data well.
Discussion
This is the first study to examine factors correlated with a short survival in patients with advanced cancer followed at home. It also was a first attempt to identify some simple variables, easy to measure at home, that can be evaluated in larger studies. Moreover, analysis was based on intensity of symptoms, as measured by the ESAS, rather than on the mere presence or absence of symptoms. Numerous factors have been found to be implicated in short survival. A high level of symptom burden is likely to be associated with a shorter survival 12 as well as other signs, such as tachycardia and low systolic blood pressure, which are indirect signs of autonomic dysfunction. All factors implicated in respiratory function (dyspnea, cyanosis, the use of oxygen) were associated with a shorter survival, whereas psychological factors or pain intensity were not determinant. In a multivariate analysis, low systolic blood pressure and high heart rate, gender, delirium, the use of oxygen, lower KPS scores, drowsiness, appetite loss, and dyspnea were confirmed to be correlated with a survival of less than 10 days. These factors are meaningful and easy to assess. Males had a shorter survival. This result was not expected and only can be explained by later admission to home care in comparison with women, rather than to diseases prevalent in males, as no differences were found in primary diagnosis. Of interest, in a multiple logistic regression model, the ESAS distress score did not influence survival, underscoring the relevance of some specific physical symptoms over others. Finally, it is likely that some parameters, which were found altered only in a small number of patients, might possibly interfere with survival when analyzed in a larger sample of patients. Thus, these parameters should be better assessed in a prognostic model in studies with greater numbers of home care cancer patients.
Studies of cancer patients admitted to home care programs are lacking in the literature, so we were not able to make any comparisons. Many studies published in the last few years, performed in different settings, have allowed the development of various tools to estimate survival, such as clinical prediction of survival, principally based on experience and subject to many biases; the Palliative Prognostic Score; the Palliative Performance Index; and others. Some of these tools require biological markers, which are unreliable or difficult to perform at home.
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Recent reviews provide information about predicting survival in patients with advanced disease in the general population.
2e4 Irrespective of the underlying type of malignancy, most patients with advanced cancer experience a prolonged period of gradual decline and then a short phase of accelerated decline in the last weeks of life. The main indicators of this final phase are poor performance status; weight loss; symptoms such as appetite loss, breathlessness, or confusion; and abnormalities on some laboratory parameters, including high white cell count, lymphopenia, hypoalbuminemia, and elevated lactate dehydrogenase or C-reactive protein. 4, 5, 13 Recently, a two-week survival prognostic model that incorporated both biochemical markers and the presence of appetite loss, dyspnea, and edema 14 was used in a palliative care unit.
Prognostic methods also have been reported, based only on clinical signs. The ESAS, which has been used to assess symptom burden and monitor changes after clinical interventions, 15, 16 was used in the present study, and as it is validated in different languages, it may be useful for home care teams as a means of survival prediction. Recently, ESAS scores have been found to worsen in the last four weeks before death compared with those in the previous months. 17 Shortness of breath has been associated with a higher risk of dying in an acute palliative care unit but was unevaluable on multivariate analysis because of a large number of missing data. The observation that tachypnea and oxygen use were both significant highlights the prognostic importance of respiratory failure and its accompanying signs. 11 However, these data were predictors of inpatient mortality rather than length of survival.
In a recent study, fatigue, shortness of breath, lack of appetite, and feeling sad, as assessed by the M. D. Anderson Symptom Inventory, were found to be independent prognostic factors for survival time in hospitalized cancer patients, with a mean survival of 49 days. 18 Similarly, appetite loss, drowsiness, dyspnea, and fatigue were found to be associated with time to death, with a mean survival of 36 days. 12 These data were obtained, however, in the hospital or outpatient clinic setting, and symptoms were evaluated at the last assessment in the palliative care clinic, which was, on average, about five weeks before death.
Of interest, psychological symptoms were not significantly associated with survival, as observed in the present study performed at home. This finding was expected, possibly because psychological symptoms are persistent in the different phases of disease, even when physical symptom burden is less prominent. Similar results have been reported in recent studies using the ESAS. 12, 19 The ESAS, however, may not be a reliable or specific measure for psychological symptoms. 20 In another study, for example, depressive symptoms were studied longitudinally using the Beck Depression Inventory, a validated measure for depression. In contrast to the flat pattern found with the ESAS, depression increased in a curvilinear fashion toward the end of life. 21 The limited psychometric evidence supports the need for further ESAS validation studies. 22 Surprisingly, hemodynamic values have never been included in previous prognostic models, despite the likelihood that these parameters are meaningfully associated with a short survival and are worthy of appropriate assessment. Of interest, tachycardia was associated with death in an acute palliative care unit. 11 This study has obvious limitations, given the exploratory nature of this approach and the limited number of patients recruited in two home care programs. These findings need further evaluation in larger prospective studies. However, the findings of this trial may provide useful information for new prognostic models to be tested and validated for use with those patients followed at home.
In conclusion, information about survival in patients with advanced cancer followed at home is of the utmost importance to patients, families, and clinicians, and assessment of simple parameters associated with short survival may be helpful. Low systolic blood pressure and high heart rate, gender, low KPS score, appetite loss, and dyspnea were correlated with a survival of less than 10 days. The combination of physical symptoms of the ESAS and other parameters included in this study, which are simple to assess and repeatable at home, should be further explored in future studies with larger numbers of patients to construct survival models.
